NCT02141711View on ClinicalTrials.gov

TAK-438 - Safety, Blood Levels & Effects of Repeated Doses

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Erosive Esophagitis(EE)Gastroesophageal Reflux Disease (GERD)

Interventions

DRUG

TAK-438

TAK-438 tablets

DRUG

TAK-438 Placebo

TAK-438 placebo-matching tablets

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY